LATEST MANUSCRIPTS IN Journal of Clinical Virology Plus
Christopher W Dukes, Renata Am Rossetti, Jonathan A Hensel, Sebastian Snedal, Christopher L Cubitt, Michael J Schell, Martha Abrahamsen, Kimberly Isaacs-Soriano, Kayoko Kennedy, Leslie N Mangual, Junmin Whiting, Veronica Martinez-Brockhus, Jessica Y Islam, Julie Rathwell, Matthew Beatty, Amy M Hall, Daniel Abate-Daga, Anna R Giuliano, Shari Pilon-Thomas. SARS-CoV-2 antibody response duration and neutralization following natural infection.Journal of clinical virology plus. 2023, 3 (3):
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, Sade Ogunsola, Akin Osibogun, Fatima Onawoga, Sarah John-Olabode, Iorhen E Akase, Augustina Nwosu, Donald J Hamel, Charlotte A Chang, Phyllis J Kanki. High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses.Journal of clinical virology plus. 2023, 3 (3): 100156
Thomas Perkmann, David N Springer, Patrick Mucher, Michael Wolzt, Lukas Weseslindtner, Helmuth Haslacher. Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations.Journal of clinical virology plus. 2023, 3 (3): 100157
Victor Dos Santos Barboza, William Borges Domingues, Thobias Toniolo de Souza, Tiago Veiras Collares, Fabiana Kommling Seixas, Bruna Silveira Pacheco, Fernanda Severo Sabedra Sousa, Thaís Larré Oliveira, Marcelo de Lima, Claúdio Martin Pereira de Pereira, Fernando Rosado Spilki, Janice Luehring Giongo, Rodrigo de Almeida Vaucher. Reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay as a rapid molecular diagnostic tool for COVID-19 in healthcare workers.Journal of clinical virology plus. 2023, 3 (2): 100134
Christien Rondaan, Lilli Gard, Hubert G M Niesters, Coretta van Leer-Buter, Xuewei Zhou. COVID or no COVID: Interpreting inconclusive SARS-CoV-2 qPCR results in different populations and platforms.Journal of clinical virology plus. 2023, 3 (2): 100145
Sudhakar Natarajan, Mohan Ranganathan, P L Natarajan, Manohar Nesakumar, S Anbalagan, K Lucia Precilla, H Hemalatha, M Kannan, G Narendran, S Mahalakshmi, Gomathi Karmegam, Lakshmi Prakash, K Narayanasamy, Luke Elizabeth Hanna. Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVID-19 pandemic in Chennai, India.Journal of clinical virology plus. 2023, 3 (2): 100146
Bart K Chwalisz, Vi K Le, Jennifer R Cheng, Aayushee Jain, M Brandon Westover, Hsinlin T Cheng. COVID-19-induced headache in Boston and the vicinity.Journal of clinical virology plus. 2023, 3 (2): 100148
Paola Mazzetti, Pietro Giorgio Spezia, Anna-Lisa Capria, Giulia Freer, Maria Sidoti, Silvia Costarelli, Alice Cara, Alfredo Rosellini, Susi Frateschi, Giovanna Moscato, Iacopo Franconi, Michele Curcio, Maria Linda Vatteroni, Michele Lai, Paola Quaranta, Daniele Focosi, Spartaco Sani, Mauro Pistello. SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses.Journal of clinical virology plus. 2023, 3 (2): 100149
Sahar K Hegazy, Samar Tharwat, Ahmed H Hassan. Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients.Journal of clinical virology plus. 2023, 3 (2): 100151
Frank Bernhard Kraus, Stefan Moritz, Könül Mamadova, Mario Popp, Marija Kocijancic, Beatrice Ludwig-Kraus. When rare becomes common: N2 gene-positive, E gene-negative SARS-CoV-2 PCR results between 2021 and 2022.Journal of clinical virology plus. 2023, 3 (2): 100152
Daniele Focosi, Federico Gueli, Cesare Gruber, Emanuela Giombini, Fabrizio Maggi. Analysis of SARS-CoV-2 sublineages reported from local cases in mainland China (September 2022-January 2023) and surveillance of outbound passengers.Journal of clinical virology plus. 2023, 3 (2): 100153
Daniele Focosi, Massimo Franchini, Jonathon W Senefeld, Arturo Casadevall, Michael J Joyner. Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines.Journal of clinical virology plus. 2023, 3 (1): 100128
Maria-Eleni Parakatselaki, Georgia Alexi, Alexandros Zafiropoulos, George Sourvinos. Evaluation of STANDARD M10 SARS-CoV-2 assay as a diagnostic tool for SARS-CoV-2 in nasopharyngeal or oropharyngeal swab samples.Journal of clinical virology plus. 2023, 3 (1): 100129
Latha Dulipsingh, Maxine Lang, Margaret R Diffenderfer, Lisa Cook, Jennifer Puff, Lynn Diaz, Lihong He, Ernst J Schaefer. Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) serology in the vaccination era and post booster vaccination.Journal of clinical virology plus. 2023, 3 (1): 100130